Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma

Alpha-Methylacyl-CoA racemase (AMACR), which was initially discovered as a prostate cancer marker, is critical for the chiral inversion mechanism of branched-chain fatty acids. However, the function of AMACR in brain tumors has not been investigated. In this study, AMACR appeared to be involved in g...

Full description

Bibliographic Details
Main Authors: Hyunji Lee, Minhee Kim, Seon-Hwan Kim, Quangdon Tran, Gyeyeong Kong, Chaeyeong Kim, So Hee Kwon, Jisoo Park, Jin Bong Park, Sungjin Park, Jongsun Park
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
alpha-methylacyl-CoA racemase
glioblastoma
brain
cancer
biomarker
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.550673/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.550673/full

Similar Items